Sign Up For Our Newsletter
Sign Up For Our Newsletter

Day

September 29, 2020
In recent years, “sustainable investing”— meaning investment strategies that incorporate environmental, social, and governance (ESG) factors alongside traditional financial analysis — has grown considerably in attention and assets under management (AUM). According to a 2018 study, more than $12 trillion in assets in the U.S. alone were managed in a sustainable process, compared to $639...
Read More
Come join the Family Office Networks Webinar Series featuring Revance. Revance Therapeutics (NASDAQ: RVNC) is a Silicon Valley-based biotechnology company, pioneering new innovations in neuromodulators for aesthetic and therapeutic indications. Tobin Schilke, Chief Financial Officer and Dustin Sjuts, Chief Commercial Officer, Aesthetics & Therapeutics, will speak about the advantages of its next-generation neuromodulator, DaxibotulinumtoxinA for Injection, not only for...
Read More